Abstract:Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Persistent infection with high-risk human papillomaviruses (HPV) types is essential for the development of cervical cancer and its immediate precursor, cervical intraepithelial neoplasia 3 (CIN3). However, HPV infection alone is not sufficient to promote cervical carcinogenesis, thus it is hypothesized that the progression to invasive disease is dependent on viral and host factors. For example, it is well established that HPV integration into the host genome is a signature of invasive cervical cancer (ICC). Also, HPV genomes have CpG sites scattered throughout their genes that, with advancing disease, are increasingly methylated by the host cell's DNA methyltransferases. This methylation may alter the expression patterns of viral genes that are relevant to transformation. The goal of the current study was to investigate the landscape of viral-host integration and associated methylation in CIN and ICC. DNA from the lesions of patients diagnosed with either CIN or ICC was captured utilizing HPV and target gene enrichment and next-generation sequencing. DNA libraries were prepared using SureSelectXT Methyl-Seq Target Enrichment Kit (Agilent Technologies) and hybridized with a custom SureSelectXT Library (Agilent Technologies) designed to target 63 HPV types and xGen Lockdown Probes (Integrated DNA Technologies) designed to target 6 cancer-relevant genes. Library samples were pooled and sequenced using the Illumina HiSeq 2000. Bisulfate treated sequence reads obtained from Illumina Hi-Seq 2000 were analyzed by MethylCoder that generates per-base resolution of methylation data. In MethylCoder, the Genomic short-read nucleotide alignment program (GSNAP) was used for aligning short reads into reference genomes (HPV and hg19). For each CpG site, the methylation rate was calculated as the percentage of unconverted cytosines in each sample. In support of previous work, we found that multiple HPV types exhibited integration into various host genes in ICC. Also, HPV integration occurs in different patterns within the same gene. For example, in one tumor, HPV16 exhibited three distinct integrations into the PVT1 oncogene. Global methylation patterns were found to be unique among HPV types and samples, yet preliminary analysis suggests that the percent methylation in HPV may track with that of the host genome. Further, the overall methylation pattern of the virus was significantly different in CIN versus ICC. Here we provide a discussion of specific nonrandom integration sites across multiple ICC samples and representative HPV methylation profiles from CIN and ICC samples. Our data provide novel insights into the HPV CpG methylation sites and gene targets at viral-cellular junctions of different HPV types from CIN through ICC, thus potentially identifying new biomarkers for use in the screening and diagnosis of cervical cancer. Citation Format: Marissa Iden, Samantha Fye, Yi-Wen Huang, Pengyuan Liu, Janet S. Rader. HPV integration and methylation patterns in cervical intraepithelial neoplasia and invasive cervical cancer via HPV capture and high-throughput sequencing. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3173. doi:10.1158/1538-7445.AM2014-3173

Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy

Methylation Status of the Long Control Region of Hpv 16 in Clinical Cervical Specimens

Digital RNA Sequencing of Human Epidermal Keratinocytes Carrying Human Papillomavirus Type 16 E7

Searching for the methylation sites involved in human papillomavirus type 16 and 18‑positive women with cervical cancer

Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions

Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral Dna in Head and Neck Cancers

Hpv Integration And Methylation Patterns In Cervical Intraepithelial Neoplasia And Invasive Cervical Cancer Via Hpv Capture And High-Throughput Sequencing

Supplementary Figure S4. Distinct HPV Methylation in Genic Regions Between CIN and ICC and CIN3 and SCC from Targeted, Deep Sequencing Reveals Full Methylation Profiles of Multiple HPV Types and Potential Biomarkers for Cervical Cancer Progression

Increased Methylation of Human Papillomavirus Type 16 DNA is Associated with the Severity of Cervical Lesions in Infected Females from Northeast China

Transcriptome Sequencing Profiles of Cervical Cancer Tissues and SiHa Cells

Discovery and Development of Differentially Methylated Regions in Human Papillomavirus‐related Oropharyngeal Squamous Cell Carcinoma

Aberrant Dna Methylation in Cervical Carcinogenesis

Human Papillomavirus 16 DNA Methylation Patterns and Investigation of Integration Status in Head and Neck Cancer Cases

Genome-wide host methylation profiling of anal and cervical carcinoma

Methylation of CpG 5962 in L1 of the human papillomavirus 16 genome as a potential predictive marker for viral persistence: A prospective large cohort study using cervical swab samples

A novel human papillomavirus and host DNA methylation score and detection of cervical adenocarcinoma

Supplementary Figure S2. Probability Density of Proportion of Mapped Reads in HPV-negative Samples from Targeted, Deep Sequencing Reveals Full Methylation Profiles of Multiple HPV Types and Potential Biomarkers for Cervical Cancer Progression

Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma

Molecular Pap Smear: Validation of HPV Genotype and Host Methylation Profiles of ADCY8, CDH8, and ZNF582 as a Predictor of Cervical Cytopathology

HPV‐related Methylation‐based Reclassification and Risk Stratification of Cervical Cancer

Correlation Between Severity of Cervical Lesions and Methylation of Human Papilloma Virus Type 16 DNA